Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Filings indexed 416 across all filing types
Latest filing 2018-07-27 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number' and contains a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form, detailing an acquisition or disposal of voting rights by a shareholder (SOUTHERN FOX INVESTMENTS LTD.) crossing a threshold (Over 22%). This structure is characteristic of regulatory notifications concerning significant changes in share ownership. The presence of 'RNS Number' and the explicit mention that 'This information is provided by RNS, the news service of the London Stock Exchange' strongly suggests a regulatory filing. Since the content specifically details a change in major shareholding, the most appropriate code is 'MRQ' (Major Shareholding Notification). While RNS is a general category, MRQ is more specific to the content.
2018-07-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly starts with 'RNS Number : 8980V' and contains the standard structure of a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing type (TR-1) detailing a change in holding percentage (5.5382%), making MRQ the most precise classification over the general RNS fallback.
2018-07-26 English
Results of Placing and Subscription
Major Shareholding Notification Classification · 99% confidence The document is identified by the RNS Number header and the explicit mention that the information is provided by RNS, the news service of the London Stock Exchange. The content details the 'Results of Placing and Subscription,' which involves raising capital through the issuance of new ordinary shares (£10.6 million raised). This activity directly relates to capital structure changes and fundraising. While it involves share issuance (SHA) and capital raising (CAP), the primary nature of this specific announcement, distributed via RNS, is a regulatory disclosure regarding a significant financing event. Since the definitions prioritize specific financial events, 'Capital/Financing Update' (CAP) is highly relevant. However, given the context of being a formal announcement distributed through the RNS system, and the content focusing on the successful completion of a share placement/subscription, it fits well under the 'Capital/Financing Update' (CAP) category, which covers fundraising and capital structure changes. It is not a general regulatory filing (RNS) because it is highly specific to a financing event. It is not a share issue announcement (SHA) in the sense of a stock split or rights issue, but rather a placement to raise funds, making CAP the most precise fit among the specific financial codes.
2018-07-19 English
Proposed placing & subscription to raise £10.6m
Capital/Financing Update Classification · 98% confidence The document is identified by the RNS Number (1316V) and the date (19 July 2018). The content explicitly announces a 'Proposed placing and subscription to raise up to £10.6 million' involving the issuance of 'New ordinary shares'. This activity—raising capital through the issuance of new shares via a placing/subscription—falls directly under the definition of Capital/Financing Update (CAP). Although it is distributed via RNS, the primary subject matter is capital raising, making CAP the most specific classification. It is not a general regulatory filing (RNS) because the subject is highly specific to financing.
2018-07-19 English
BLOCK LISTING SIX MONTHLY RETURN
Remuneration Information Classification · 99% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'National Storage Mechanism | Additional information'. The content details a 'BLOCK LISTING SIX MONTHLY RETURN' concerning unallotted securities under an incentive plan and provides the 'Total Voting Rights'. This structure—a formal notification filed via the RNS system (the news service of the London Stock Exchange, approved by the FCA)—indicates a general regulatory announcement that doesn't fit the more specific categories like 10-K, ER, or DIV. Therefore, it falls best under the general Regulatory Filings category.
2018-07-16 English
Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
Regulatory Filings Classification · 99% confidence The document is a short announcement (4119 characters) from 'Hardman & Co Research' regarding Allergy Therapeutics (AGY). It provides a brief summary of performance and explicitly states, 'Please click here for the full report:' followed by a PDF link. This structure—a brief summary announcing the availability of a detailed report—fits the definition of a Report Publication Announcement (RPA). It is not the full report itself (like 10-K or IR), nor is it a standard regulatory filing like an ER or MRQ, but rather an announcement about research publication.
2018-07-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.